How to use Technologies offered
A search for a cancer, preclinical stage, synthetic opportunity would use the selection "Therapeutics, Diagnostics" in 'Sector', 'Cancerous, neoplasmatic' in 'Disease Category', 'Drugs, Small Molecule' in 'Technology' and 'Preclinical' in 'Development Stage'.
Selection of 'Enabling Technology, Platform Technology' in 'Sector' will identify all kinds of research technologies that can be used in more areas of life sciences than pharmaceuticals only.
Each technology profile gives the name of a company or academic institute as source of the offer, and a link allowing to contact the potential licensor. In most cases a profile includes a pdf covering the available non-confidential information as well as detailed contact data.
Registered users can create non-public notifications profiles which will inform them about new 'Technologies Offered' entries fitting their needs as specified. In addition these profiles allow them to filter the available information more comfortably.
Composed of an assortment of twenty-one libraries including FDA-approved drug library, natural product library, and anti-cancer compound library, among others, the bioactive screening libraries at BOC Sciences are ready-to-use chemical libraries for drug discovery, lab drug screening, drug target identification, and other pharmaceutical-related applications.
These libraries consist of a unique and diverse collection of thousands of compounds with validated biological and pharmacological activities, in which each library corresponds to a particular category of materials that can be harnessed for high screening and high content screening.
For quality assurance purposes, a full characterization report or a Certificate of Analysis (COA) is prepared and NMR spectroscopy and HPLC chromatography performed to validate the purity level and chemical structure of every compound supplied by BOC Sciences.
To view the contact information, attachments and url of this profile you have to login into your account or register a new account: Login
Please click here to log in to view the complete profile.